| Challenge Owner(s) |
Yusen Logistics, Mitsubishi Chemical Holdings, Teijin Pharma
|
|---|---|
| Organiser(s) | SGInnovate |
| Industry Type(s) |
Circular Economy & Sustainability, Digital/ICT, Environmental Services, Healthcare & Biomedical, Logistics
|
| Opportunities and Support | Opportunities to co-develop, testbed solutions and hold pilot programs with challenge statement owners |
| Application Start Date | 17 February 2022 |
| Application End Date | 11 March 2022 |
| Website | Click here to learn more |
About Challenge
Presented by SGInnovate, EDB and in partnership with JETRO, the Reverse Pitch event series aims to spotlight market demands for frontier technologies to better inform the startup community to support their go-to-market efforts. At these Reverse Pitch events, corporate leaders will present their problem statements and innovation needs that they are open to working with startups. This session will feature business needs in industries such as Healthcare, Supply Chain, and Sustainability from leading Japanese MNCs such as Teijin Pharma, Yusen Logistics Co., Ltd. and Mitsubishi Chemical Holdings.Learn More
| Challenge Owner(s) | Teijin Pharma |
|---|---|
| Industry Types(s) | Digital/ICT, Healthcare & Biomedical |
Teijin Pharma
Teijin Pharma Limited (Teijin) is looking for solutions to treat neurological diseases in the Japanese population.
Hardware MedTech startups for neuromodulation and software startups experience in healthcare for a mobile app would be relevant.
What We Are Looking For
To save and reduce patients with neurological diseases relating to the central nervous system, including psychiatric and neurodegenerative diseases. Solution examples include user-friendly therapeutic modalities like non-invasive neuromodulation and/or digital therapeutics at home.
Working Model:
Teijin is open to discussing the collaboration model with startups but typically takes responsibility for technology development for the Japanese market, conducting clinical studies, regulatory / reimbursement tasks and finally commercialisation in Japan.
To achieve the goal, Teijin will invest with dilutive (equity) and/or non-dilutive funding in the partner(s).
Learn More
| Challenge Owner(s) | Yusen Logistics |
|---|
Yusen Logistics
Freight transport is a large contributor to emissions of CO2 and customers look for supply chain partners who prioritise Environmental, Social and Governance (ESG) goals. Customers often request for a carbon footprint metrics tool to measure and report CO2 emissions to evaluate both the economic and environmental costs of a particular logistics solution.
For air and ocean freight forwarding, the estimated amount of CO2 emissions can be calculated through current shipment data from the organisation’s operations system.
For land transportation services, Yusen Logistics owns in-house trucks and also works with outsourced fleet service providers. With the outsourced fleet service providers, they do not provide CO2 data as it is complex and time-consuming to collect the data and information for CO2 calculations.
What We Are Looking For
To be able to collect, measure and report CO2 emissions for both in-house trucks and outsources fleet service providers for land transportation services, including calculations that are performed on a regular basis to track the organisation’s performance and evaluate the effect of different measures to lower the emissions.
Working Model:
Yusen Logistics is open to discussing the collaboration model with startups.
Learn More
| Challenge Owner(s) | Mitsubishi Chemical Holdings |
|---|---|
| Industry Types(s) | Digital/ICT, Healthcare & Biomedical |
Mitsubishi Chemical Holdings
One of the future growth pillars for Mitsubishi Chemical Holdings Corporation’s (MCHC) healthcare business is to provide ‘around the pill solutions’ enabled by digital technology, intended to improve the quality of life of patients and their families, in their core therapeutics areas. Therapeutics areas of interest include the central nervous system (especially neuromuscular disease), autoimmune diseases and metabolic diseases.
What We Are Looking For
To establish multiple touchpoints with patients during the patient journey from prevention to prognosis, to collect and analyse healthcare data and expand the value of current treatments.
Examples of such solutions could be digital platforms enabling patient-centric disease management, electronic patient-reported outcomes, digital diagnostics, disease tracking, digital medication management, digital biomarker, etc.
Working Model:
MCHC is open to strategic investments as well as partnership opportunities with digital health startups in Asia Pacific who have their product ready for a feasibility study.
Learn More| Challenge Owner(s) | Teijin Pharma |
|---|
Teijin Pharma
Teijin Pharma Limited (Teijin) is looking for solutions for the ageing population to correctly understand their own health conditions.
Startups with capabilities to develop AI algorithms based on health / vital data for chronic diseases and startups with technologies for sensing vital signals for chronic diseases would be relevant.
What We Are Looking For
To provide an easy solution for the ageing population with chronic diseases to proactively understand their own health conditions from the patients’ homes. This includes, but should not be limited to, innovative technology to predict exacerbation before their illness gets worse.
Working Model:
Teijin is open to discussing the collaboration model with startups but typically takes responsibility for technology development for the Japanese market, conducting clinical studies, regulatory / reimbursement tasks and finally commercialisation in Japan.
To achieve the goal, Teijin will invest with dilutive (equity) and/or non-dilutive funding in the partner(s).
Learn More
| Challenge Owner(s) | Yusen Logistics |
|---|---|
| Industry Types(s) | Circular Economy & Sustainability, Logistics |
Yusen Logistics
Sustainability is a top priority in Yusen Logistics as many customers are working towards public green initiatives. They are looking for service partners who prioritise corporate responsibilities as well.
What We Are Looking For
As the effects of climate change worsen, logistics companies’ ESG objectives are more important than ever. The steps to achieving optimal ESG performance are crucial and Yusen Logistics welcomes any proposal to support their ESG goals.
Working Model:
Yusen Logistics is open to discussing the collaboration model with startups.
Learn More
| Challenge Owner(s) | Yusen Logistics |
|---|---|
| Industry Types(s) | Circular Economy & Sustainability, Logistics, Urban Solutions |
Yusen Logistics
The logistics supply chain generates waste at every turn. The types of waste include transport packaging materials, lashing materials, cushioning materials and desiccant agents which are produced in logistics operations and pose significant environmental issues.
Currently, there is no proper waste management system and solutions for our supply chain. Yusen Logistics is looking to reduce internal costs and prioritise its ESG goals by optimising its supply chain with waste reduction and separation techniques.
What We Are Looking For
To address waste and recycling services with a holistic approach (tailored to individual location’s needs), to reduce waste volumes at the end of a material’s life, to measure and reduce waste in logistics operation efficiently, and to be able to trace the end-of-life of packing and transport material.
Working Model:
Yusen Logistics is open to discussing the collaboration model with startups.
Learn More
Sign up for the latest innovation updates
Customise your preferences to receive updates in industries you're interested in.